This inventor holds 1 USPTO granted patent. Top assignees: Taiwan Liposome Company, Ltd., Tlc Biopharmaceuticals, Inc.. Active years: 2012.
Company Filing History:
1 out of 29 
1 out of 32 Years Active: 2012
Title: Siong-Tern Liew: Innovator in Anticancer Therapeutics
Introduction
Siong-Tern Liew is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. His innovative work has led to the creation of new compounds that hold promise for cancer therapies.
Latest Patents
Liew holds a patent for "Camptothecin derivatives and uses thereof." This invention provides two new camptothecin derivatives, identified as S,R- and S,S-topotecan lactates. Both compounds exhibit anticancer activities, and the patent also includes pharmaceutical compositions of these derivatives, along with potential cancer therapies utilizing them.
Career Highlights
Throughout his career, Siong-Tern Liew has worked with reputable organizations, including Taiwan Liposome Company, Ltd. and Tlc Biopharmaceuticals, Inc. His experience in these companies has allowed him to advance his research and contribute to the development of effective cancer treatments.
Collaborations
Liew has collaborated with several professionals in his field, including Min-Wen Kuo and Yung-Hsu Chan. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Siong-Tern Liew's contributions to the field of anticancer therapeutics through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to inspire advancements in cancer treatment.